Host: |
Rabbit |
Applications: |
WB |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CNTROB (604-903) is suitable for use in Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
Unconjugated |
Isotype: |
IgG |
Formulation: |
PBS with 0.02% Sodium Azide, 50% Glycerol, pH7.3. |
Purification: |
Affinity purification |
Dilution Range: |
WB 1:500-1:2000 |
Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
Gene Symbol: |
CNTROB |
Gene ID: |
116840 |
Uniprot ID: |
CNTRB_HUMAN |
Immunogen Region: |
604-903 |
Immunogen: |
Recombinant fusion protein containing a sequence corresponding to amino acids 604-903 of human CNTROB (NP_444279.2). |
Immunogen Sequence: |
PMAVALKPVLQQSREARDEL PGAPPVLCSSSSDLSLLLGP SFQSQHSFQPLEPKPDLTSS TAGAFSALGAFHPDHRAERP FPEEDPGPDGEGLLKQGLPP AQLEGLKNFLHQLLETVPQN NENPSVDLLPPKSGPLTVPS WEEAPQVPRIPPPVHKTKVP LAMASSLFRVPEPPSSHSQG SGPSSGSPERGGDGLTFPRQ LMEVSQLLRLYQARGWGALP AEDLLLYLKRLEHSGTDGR |
Tissue Specificity | Widely expressed (at protein level). Highly expressed in testis. Also expressed in spleen, thymus, prostate, small intestine, colon and peripheral blood leukocytes. |
Function | Required for centriole duplication. Inhibition of centriole duplication leading to defects in cytokinesis. |
Protein Name | CentrobinCentrosomal Brca2-Interacting ProteinLyst-Interacting Protein 8 |
Cellular Localisation | CytoplasmCytoskeletonMicrotubule Organizing CenterCentrosomeCentrioleCentriole-AssociatedAsymmetrically Localizes To The Daughter Centriole |
Alternative Antibody Names | Anti-Centrobin antibodyAnti-Centrosomal Brca2-Interacting Protein antibodyAnti-Lyst-Interacting Protein 8 antibodyAnti-CNTROB antibodyAnti-LIP8 antibodyAnti-PP1221 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance